ACRV
Acrivon Therapeutics, Inc.
+0.03 (+1.47%)1.73USD268K成交股數73.9M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 13.8M | 15.2M | 14.7M | 13.6M | 16.2M | 15.4M | 18.9M | 15.0M | 11.5M | 15.5M | 10.3M | 10.5M |
| 銷售管理費用 | 4.8M | 4.7M | 5.4M | 6.0M | 6.5M | 6.2M | 6.3M | 6.4M | 6.2M | 5.6M | 5.9M | 5.0M |
| 營業利益 | −18.7M-18% | −19.9M-8% | −20.1M-20% | −19.7M-8% | −22.6M+28% | −21.7M+3% | −25.1M+56% | −21.4M+38% | −17.7M | −21.1M | −16.1M | −15.5M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −18.0M-14% | −19.0M-3% | −19.0M-15% | −18.2M-3% | −21.0M+27% | −19.7M+2% | −22.4M+55% | −18.8M+35% | −16.5M | −19.3M | −14.5M | −13.9M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.43-22% | -0.49-4% | -0.49-17% | -0.47-10% | -0.55-25% | -0.51-41% | -0.59-11% | -0.52-17% | -0.73 | -0.87 | -0.66 | -0.63 |
| 稀釋股數 | 41.8M | 38.7M | 38.5M | 38.6M | 38.5M | 38.4M | 38.1M | 36.1M | 22.6M | 22.1M | 22.1M | 22.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 41.4M | 34.1M | 41.5M | 35.4M | 41.9M | 39.2M | 43.4M | 46.0M | 24.6M | 36.0M | 29.9M | 38.1M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 99.1M | 108M | 130M | 145M | 159M | 176M | 215M | 231M | 121M | 138M | 151M | 160M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 12.4M | 12.3M | 17.2M | 16.7M | 15.5M | 16.0M | 17.8M | 14.5M | 12.5M | 17.1M | 12.9M | 10.9M |
| 股東權益 | 86.7M | 95.5M | 113M | 129M | 143M | 160M | 197M | 216M | 108M | 121M | 138M | 149M |
| 負債比 | 12.5% | 11.4% | 13.3% | 11.5% | 9.8% | 9.0% | 8.3% | 6.3% | 10.4% | 12.3% | 8.6% | 6.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −20.5M+5% | – | – | – | −19.5M | – | – | −17.1M | – | – | – |
| 資本支出 | – | 14K | – | – | – | 58K | – | – | 815K | – | – | – |
| 自由現金流 | – | −20.6M+5% | – | – | – | −19.6M | – | – | −17.9M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −77.9M | –% | -2.02 | −65.3M |
| FY2024 | – | – | −80.6M | –% | -2.38 | −68.4M |
| FY2023 | – | – | −60.4M | –% | -2.74 | −43.9M |
| FY2022 | – | – | −31.2M | –% | -7.56 | −32.3M |
| FY2021 | – | – | −16.2M | –% | -9.32 | −14.2M |